Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screening

cfDNA sequencing for fetal aneuploidy may detect chromosomal abnormalities representative of maternal malignancy. Maternal malignancy must be considered when abnormal cfDNA sequencing for fetal aneuploidy is associated with normal fetal karyotype.

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood Adv
Päätekijät: Luskin, Marlise R., Discenza, Marie N., Easter, Sarah Rae, Dal Cin, Paola, Owen, Renius, Ilagan, Bernard, Masiello, Meredith, Lane, Andrew A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2017
Aiheet:
Exceptional Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728472/
https://ncbi.nlm.nih.gov/pubmed/29296790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017008680
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia